Steve Parson-WPA Pool / Getty Images Innovio Pharmaceuticals fell 39% on Monday after a biotech firm announced a temporary mid-to-late seizure of the coronavirus vaccine. Innovio said the trial is on a “partial clinical hold” until it answers questions from the Food and Drug Administration, which it plans to do …
Read More »
Modern Pharmaceutical (MRNA) – Get report, one of the leading candidates to produce a viable coronavirus vaccine, fell on Monday after Oxford University and AstraZeneca (AZN) – Get report published promising data from an early-stage trial of a key coronavirus vaccine study, and the population received a downgrade from JP …
Read More »
A British pharmaceutical company said Monday that positive results from a clinical trial of a new coronavirus respiratory treatment could indicate a “breakthrough” in the global fight to stop the spread of COVID-19. Synairgen, a respiratory drug discovery and development company, said in a press release that an initial trial …
Read More »
Moderna’s shares rose as much as 18% on Wednesday after the company announced that an early test of the coronavirus vaccine produced antibodies in all participants. A dose range induced immune responses in all 45 patients in the phase 1 trial and was “generally safe and well tolerated,” Moderna said …
Read More »
Vaccine makers were climbing during Thursday’s volatile market session when investors took President Trump’s bullish proclamation on Wednesday that a vaccine to treat COVID-19 is closer than many expected to hear. Inovio Pharmaceuticals (INO) – Get report jumped more than 17% on Thursday, while Sorrento (SRNE) – Get report Almost …
Read More »